Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTaking Wegovy a day earlier than your usual injection day is something many people consider at some point during treatment — a holiday, a social event, or simply a diary clash. The short answer is that the Wegovy patient information leaflet advises sticking to the same day each week, but if your scheduled day needs to shift, the guidance allows a limited window of flexibility. This is a prescription medicine, and any change to your injection schedule should be discussed with your prescriber first. The information below explains what the clinical guidance says and how to think about your own situation.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
It's a genuinely reasonable question, and most people ask it because they care about getting their treatment right, not because they're being careless. You've built a weekly routine around injection day, and something has come up that makes this week awkward. That's a normal part of life, and the good news is the guidance does account for it.
Semaglutide (the active medicine in Wegovy) has a half-life of around one week. Because it stays in the body for a sustained period, the timing of a single dose doesn't need to be exact to the hour the way a short-acting medicine would. The NHS semaglutide information page confirms that Wegovy is taken once weekly, and the accompanying patient information leaflet states that if you need to change your injection day, you may do so as long as at least 48 hours have passed since your last dose.
So taking it one day early (24 hours ahead of schedule) would put the gap between doses at six days rather than seven. That sits within the 48-hour minimum the leaflet describes. It is not the same as skipping a dose or doubling up. The operative rule is the gap, not the calendar day.
That said, the leaflet also says this flexibility is for one-off adjustments, not a routine of shifting your day week to week. Your prescriber is the right person to confirm whether an early injection is appropriate for you at your current dose and stage of treatment. If you're on a higher maintenance dose, the clinical picture is worth a quick check before you change anything.
Because Wegovy's mechanism depends on gradual, sustained exposure rather than sharp peaks, a six-day gap instead of seven is unlikely to produce a clinically significant change in how the medicine behaves. The drug accumulates in the body over several weeks of treatment, by the time most people reach their maintenance dose, levels are relatively stable from week to week.
A one-day shortening of the interval means a slightly higher concentration in the body than usual at the point of the next injection. For most people at any stage of treatment, this is a small and transient shift. The effects most likely to be felt are gastrointestinal (nausea, reduced appetite, or stomach discomfort) which tend to be more noticeable when semaglutide levels are rising or slightly higher than usual. These are the same effects that prompted the gradual titration schedule in the first place.
If you've recently increased your dose and your body is still adjusting, that context matters. The NHS England guidance on weight management injections underscores the importance of clinical oversight throughout treatment, your prescriber knows your dose history and is placed to judge whether a timing adjustment is straightforward or worth pausing on.
You can read more about the practical aspects of your treatment schedule on our Wegovy treatment page.
If you decide, after speaking with your prescriber, that taking Wegovy a day early is appropriate this week, the practicalities are straightforward. Inject as normal, in one of your usual sites (abdomen, thigh, or upper arm), and then reset your weekly day to the new date going forward if that's the intention, or return to the original day the following week if it was a one-off.
What the leaflet is clear about: do not take two injections close together to make up for an awkward week. The minimum 48-hour gap is a floor, not a suggestion. Taking two doses within that window is not the same as adjusting your day, it is a double dose, and that is not recommended.
It's also worth knowing that if you're considering the cost or logistics of your treatment and weighing up whether a schedule change makes sense, our Wegovy price comparison guide sets out what a complete private prescription service actually covers, which is worth understanding before any break in treatment.
If you miss a dose entirely rather than taking it early, the leaflet guidance differs: take the missed dose as soon as you remember, provided it's within five days. After five days, skip that injection and continue with your next scheduled dose. Missing a single dose is not a reason to abandon treatment, but a pattern of missed or erratic doses can undermine both tolerability and results. Anything recurring is a conversation for your prescriber, documented in your clinical record.
For a straightforward one-off shift of one day, the leaflet's 48-hour rule is usually the relevant fact, and our guide on taking Wegovy 1 day early walks through the practical considerations in more detail. But some situations call for a proper clinical conversation rather than a self-managed adjustment.
Those include: being in the middle of a dose increase, having experienced nausea or GI symptoms recently, taking other medicines that interact with semaglutide's effect on gastric emptying, or having any uncertainty about your treatment plan. The details of your specific situation (your dose, your history, your other medicines) are things a prescriber can weigh in a way that general guidance cannot.
Our prescribers review every patient's treatment before each repeat, and you can reach the clinical team through our support page if a question comes up between orders. For a wider look at how semaglutide works and what to expect over the course of treatment, the semaglutide overview covers the mechanism, the titration schedule, and the evidence behind it.
If you're not yet started on treatment and are considering Wegovy for weight management, you can learn more about what's involved on our weight loss treatments overview, or speak to our prescribers directly through a free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.